Cargando…
Drug repurposing strategies of relevance for Parkinson’s disease
Parkinson's disease is a highly disabling, progressive neurodegenerative disease that manifests as a mix of motor and non‐motor signs. Although we are equipped with some symptomatic treatments, especially for the motor signs of the disease, there are still no established disease‐modifying drugs...
Autores principales: | Fletcher, Edward J. R., Kaminski, Thomas, Williams, Gareth, Duty, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311732/ https://www.ncbi.nlm.nih.gov/pubmed/34309236 http://dx.doi.org/10.1002/prp2.841 |
Ejemplares similares
-
Drug repurposing and human parasitic protozoan diseases
por: Andrews, Katherine T., et al.
Publicado: (2014) -
Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021) -
Repurposing drugs for the treatment and control of helminth infections
por: Panic, Gordana, et al.
Publicado: (2014) -
Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research
por: Lama, Joana, et al.
Publicado: (2021) -
Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
por: Hashimoto, Kenji
Publicado: (2021)